Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Haddad FG, Sasaki K, Nasr L, Short NJ, et al. Cancer 2024 May 28. doi: 10.1002/cncr.35384.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Haddad FG, Sasaki K, Nasr L, Short NJ, et al. Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer 2024 May 28. doi: 10.1002/cncr.35384.
PMID: 38804723